Dasatinib combined with weekly administration of vincristine as effective therapy in sudden or resistant Ph plus lymphoid blast crisis of chronic myeloid leukaemia

被引：6
作者：
Breccia, Massimo [1 ]
Serrao, Alessandra [1 ]
Salaroli, Adriano [1 ]
Loglisci, Giuseppina [1 ]
Zacheo, Irene [1 ]
Alimena, Giuliana [1 ]
机构：
[1] Univ Roma La Sapienza, Dept Cellular Biotechnol & Haematol, Rome, Italy
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2012年 / 159卷 / 05期
关键词：
chronic myeloid leukaemia; lymphoid blast crisis; dasatinib; ACUTE LYMPHOBLASTIC-LEUKEMIA; PHILADELPHIA-CHROMOSOME; IMATINIB-RESISTANT; EFFICACY; TRANSFORMATION; MESYLATE; PHASE;
D O I：
10.1111/bjh.12079
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：612 / 613
页数：2
相关论文
共 8 条
  • [1] Sudden blast crisis in patients with Philadelphia chromosome-positive chronic myeloid leukemia who achieved complete cytogenetic remission after imatinib therapy
    Alimena, Giuliana
    Breccia, Massimo
    Latagliata, Roberto
    Carmosino, Ida
    Russo, Eleonora
    Biondo, Francesca
    Diverio, Daniela
    Mancini, Marco
    Nanni, Mauro
    Mandelli, Franco
    [J]. CANCER, 2006, 107 (05) : 1008 - 1013
  • [2] Efficacy and safety of dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blast phase
    Cortes, J.
    Kim, D-W
    Raffoux, E.
    Martinelli, G.
    Ritchie, E.
    Roy, L.
    Coutre, S.
    Corm, S.
    Hamerschlak, N.
    Tang, J-L
    Hochhaus, A.
    Khoury, H. J.
    Bruemmendorf, T. H.
    Michallet, M.
    Rege-Cambrin, G.
    Gambacorti-Passerini, C.
    Radich, J. P.
    Ernst, T.
    Zhu, C.
    Van Tornout, J. M. A.
    Talpaz, M.
    [J]. LEUKEMIA, 2008, 22 (12) : 2176 - 2183
  • [3] Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the philadelphia chromosome.
    Druker, BJ
    Sawyers, CL
    Kantarjian, H
    Resta, DJ
    Reese, SF
    Ford, JM
    Capdeville, R
    Talpaz, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) : 1038 - 1042
  • [4] Sudden blastic transformation in patients with chronic myeloid leukemia treated with imatinib mesylate
    Jabbour, E
    Kantarjian, H
    O'Brien, S
    Rios, MB
    Abruzzo, L
    Verstovsek, S
    Garcia-Manero, G
    Cortes, J
    [J]. BLOOD, 2006, 107 (02) : 480 - 482
  • [5] Efficacy of combining dasatinib and FLAG-IDA for patients with chronic myeloid leukemia in blastic transformation
    Milojkovic, Dragana
    Ibrahim, Amr
    Reid, Alistair
    Foroni, Letizia
    Apperley, Jane
    Marin, David
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (03): : 473 - 474
  • [6] High-dose imatinib mesylate combined with vincristine and dexamethasone (DIV regimen) as induction therapy in patients with resistant Philadelphia-positive acute lymphoblastic leukemia and lymphoid blast crisis of chronic myeloid leukemia
    Rea, D
    Legros, L
    Raffoux, E
    Thomas, X
    Turlure, P
    Maury, S
    Dupriez, B
    Pigneux, A
    Choufi, B
    Reman, O
    Stéphane, D
    Royer, B
    Vigier, M
    Ojeda-Uribe, M
    Recher, C
    Dombret, H
    Huguet, F
    Rousselot, P
    [J]. LEUKEMIA, 2006, 20 (03) : 400 - 403
  • [7] Dasatinib in Imatinib-Resistant or Imatinib-Intolerant Chronic Myeloid Leukemia in Blast Phase After 2 Years of Follow-Up in a Phase 3 Study Efficacy and Tolerability of 140 Milligrams Once Daily and 70 Milligrams Twice Daily
    Saglio, Giuseppe
    Hochhaus, Andreas
    Goh, Yeow Tee
    Masszi, Tamas
    Pasquini, Ricardo
    Maloisel, Frederic
    Erben, Philipp
    Cortes, Jorge
    Paquette, Ronald
    Bradley-Garelik, M. Brigid
    Zhu, Chao
    Dombret, Herve
    [J]. CANCER, 2010, 116 (16) : 3852 - 3861
  • [8] Shah Neil P, 2008, J Natl Compr Canc Netw, V6 Suppl 2, pS31
1